RECRUITING

Voice Analysis for Monitoring Patients With Heart Failure

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.

Official Title

A Pilot Study on AI-Based Voice Analysis for Monitoring Patients Hospitalized With Acute Decompensated Heart Failure

Quick Facts

Study Start:2024-01-24
Study Completion:2024-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06566911

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clinically diagnosed with Acutely Decompensated Heart Failure.
  2. * At least 18 years of age.
  1. * Disabling mental diseases (e.g., Alzheimer's disease)
  2. * Clinically diagnosed chronic obstructive pulmonary disease (COPD)
  3. * Treatment in ICU or IMU
  4. * Dialysis treatment
  5. * Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
  6. * Neurodegenerative diseases
  7. * Pregnancy
  8. * Inability to provide consent

Contacts and Locations

Study Contact

Leonhard Riehle, MD
CONTACT
+49 32 221093495
leonhard.riehle@noah-labs.com

Principal Investigator

Gerhard Hindricks, MD
PRINCIPAL_INVESTIGATOR
German Heart Institute

Study Locations (Sites)

Mayo Clinic
Rochester, Minnesota, 55902
United States

Collaborators and Investigators

Sponsor: Noah Labs

  • Gerhard Hindricks, MD, PRINCIPAL_INVESTIGATOR, German Heart Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-24
Study Completion Date2024-09

Study Record Updates

Study Start Date2024-01-24
Study Completion Date2024-09

Terms related to this study

Additional Relevant MeSH Terms

  • Heart Failure